The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Molecular Diagnostics Cancer Market Research Report 2025
Synopsis
A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.
The global Molecular Diagnostics Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Cancer.
Report Scope
The Molecular Diagnostics Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostics Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Siemens
Abbott Laboratories
ICON Plc
AstraZeneca
MDxHealth
Invitae
PlexBio
Thermo Fisher Scientific
Guardant Health
Biocartis
Bio-Techne
Merck
Foundation Medicine
10X Genomics
Biodesix
CytoTrack
GenomOncology
Luminex
Segment by Type
Pharmacogenomic Diagnosis
Liquid Biopsy
Other
Segment by Application
Respiratory Cancer
Cancer of Digestive System
Cancer of Urinary System
Cancer of Circulatory System
Motor System Cancer
Reproductive System Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.
The global Molecular Diagnostics Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics Cancer.
Report Scope
The Molecular Diagnostics Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostics Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Diagnostics Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Danaher
Siemens
Abbott Laboratories
ICON Plc
AstraZeneca
MDxHealth
Invitae
PlexBio
Thermo Fisher Scientific
Guardant Health
Biocartis
Bio-Techne
Merck
Foundation Medicine
10X Genomics
Biodesix
CytoTrack
GenomOncology
Luminex
Segment by Type
Pharmacogenomic Diagnosis
Liquid Biopsy
Other
Segment by Application
Respiratory Cancer
Cancer of Digestive System
Cancer of Urinary System
Cancer of Circulatory System
Motor System Cancer
Reproductive System Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pharmacogenomic Diagnosis
1.2.3 Liquid Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Respiratory Cancer
1.3.3 Cancer of Digestive System
1.3.4 Cancer of Urinary System
1.3.5 Cancer of Circulatory System
1.3.6 Motor System Cancer
1.3.7 Reproductive System Cancer
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Cancer Market Perspective (2019-2030)
2.2 Molecular Diagnostics Cancer Growth Trends by Region
2.2.1 Global Molecular Diagnostics Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Diagnostics Cancer Historic Market Size by Region (2019-2024)
2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Region (2025-2030)
2.3 Molecular Diagnostics Cancer Market Dynamics
2.3.1 Molecular Diagnostics Cancer Industry Trends
2.3.2 Molecular Diagnostics Cancer Market Drivers
2.3.3 Molecular Diagnostics Cancer Market Challenges
2.3.4 Molecular Diagnostics Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Cancer Players by Revenue
3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2019-2024)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2023
3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Cancer Breakdown Data by Type
4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2019-2024)
4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2025-2030)
5 Molecular Diagnostics Cancer Breakdown Data by Application
5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2019-2024)
5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Diagnostics Cancer Market Size (2019-2030)
6.2 North America Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Diagnostics Cancer Market Size by Country (2019-2024)
6.4 North America Molecular Diagnostics Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics Cancer Market Size (2019-2030)
7.2 Europe Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Diagnostics Cancer Market Size by Country (2019-2024)
7.4 Europe Molecular Diagnostics Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2019-2030)
8.2 Asia-Pacific Molecular Diagnostics Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Cancer Market Size (2019-2030)
9.2 Latin America Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Diagnostics Cancer Market Size by Country (2019-2024)
9.4 Latin America Molecular Diagnostics Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2019-2030)
10.2 Middle East & Africa Molecular Diagnostics Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Molecular Diagnostics Cancer Introduction
11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Molecular Diagnostics Cancer Introduction
11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens Molecular Diagnostics Cancer Introduction
11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.3.5 Siemens Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 ICON Plc
11.5.1 ICON Plc Company Detail
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.5.5 ICON Plc Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 MDxHealth
11.7.1 MDxHealth Company Detail
11.7.2 MDxHealth Business Overview
11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.7.5 MDxHealth Recent Development
11.8 Invitae
11.8.1 Invitae Company Detail
11.8.2 Invitae Business Overview
11.8.3 Invitae Molecular Diagnostics Cancer Introduction
11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.8.5 Invitae Recent Development
11.9 PlexBio
11.9.1 PlexBio Company Detail
11.9.2 PlexBio Business Overview
11.9.3 PlexBio Molecular Diagnostics Cancer Introduction
11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.9.5 PlexBio Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Guardant Health
11.11.1 Guardant Health Company Detail
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.11.5 Guardant Health Recent Development
11.12 Biocartis
11.12.1 Biocartis Company Detail
11.12.2 Biocartis Business Overview
11.12.3 Biocartis Molecular Diagnostics Cancer Introduction
11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.12.5 Biocartis Recent Development
11.13 Bio-Techne
11.13.1 Bio-Techne Company Detail
11.13.2 Bio-Techne Business Overview
11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.13.5 Bio-Techne Recent Development
11.14 Merck
11.14.1 Merck Company Detail
11.14.2 Merck Business Overview
11.14.3 Merck Molecular Diagnostics Cancer Introduction
11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.14.5 Merck Recent Development
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Detail
11.15.2 Foundation Medicine Business Overview
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.15.5 Foundation Medicine Recent Development
11.16 10X Genomics
11.16.1 10X Genomics Company Detail
11.16.2 10X Genomics Business Overview
11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.16.5 10X Genomics Recent Development
11.17 Biodesix
11.17.1 Biodesix Company Detail
11.17.2 Biodesix Business Overview
11.17.3 Biodesix Molecular Diagnostics Cancer Introduction
11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.17.5 Biodesix Recent Development
11.18 CytoTrack
11.18.1 CytoTrack Company Detail
11.18.2 CytoTrack Business Overview
11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.18.5 CytoTrack Recent Development
11.19 GenomOncology
11.19.1 GenomOncology Company Detail
11.19.2 GenomOncology Business Overview
11.19.3 GenomOncology Molecular Diagnostics Cancer Introduction
11.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.19.5 GenomOncology Recent Development
11.20 Luminex
11.20.1 Luminex Company Detail
11.20.2 Luminex Business Overview
11.20.3 Luminex Molecular Diagnostics Cancer Introduction
11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2019-2024)
11.20.5 Luminex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
